Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Colecalciferol as an Add-on Treatment to Subcutaneously-Administered Interferon-beta-1b for Treatment of Multiple Sclerosis (MS) (100207MS-H)

This study has been completed.
Information provided by (Responsible Party):
Merja Soilu-Hänninen, University of Turku Identifier:
First received: August 16, 2011
Last updated: September 12, 2011
Last verified: September 2011
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: August 2011
  Primary Completion Date: May 2011 (Final data collection date for primary outcome measure)